Health ❯ Healthcare ❯ Clinical Research

Trial Design

Efficacy Assessment Phase 1 Trials Endpoints Adaptive Trials Eligibility Criteria Safety and Efficacy

FDA Rejects Replimune’s Melanoma Virus Therapy Again for Insufficient Evidence

The decision underscores the FDA’s insistence on well‑controlled efficacy data over single‑arm results.

FDA Rejects Regenxbio’s Hunter Syndrome Gene Therapy Application